CHF 978.56
(0.57%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 431.93 Million CHF | 6.45% |
2022 | 405.78 Million CHF | 11.28% |
2021 | 364.65 Million CHF | 33.85% |
2020 | 272.43 Million CHF | 6.02% |
2019 | 256.95 Million CHF | 12.93% |
2018 | 227.54 Million CHF | -8.36% |
2017 | 248.29 Million CHF | 1.9% |
2016 | 243.66 Million CHF | -5.16% |
2015 | 256.92 Million CHF | 108.61% |
2014 | 123.15 Million CHF | 24.25% |
2013 | 99.12 Million CHF | -18.55% |
2012 | 121.7 Million CHF | 9.37% |
2011 | 111.27 Million CHF | 5.89% |
2010 | 105.09 Million CHF | -5.37% |
2009 | 111.05 Million CHF | -24.49% |
2008 | 147.06 Million CHF | -8.38% |
2007 | 160.52 Million CHF | 4.3% |
2006 | 153.89 Million CHF | -0.05% |
2005 | 153.96 Million CHF | 15.26% |
2004 | 133.58 Million CHF | -11.98% |
2003 | 151.77 Million CHF | 6.48% |
2002 | 142.53 Million CHF | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 464.8 Million CHF | 0.0% |
2023 Q2 | 486.5 Million CHF | 0.0% |
2023 Q4 | 431.93 Million CHF | 0.0% |
2023 FY | 431.93 Million CHF | 6.45% |
2022 Q4 | 405.78 Million CHF | 0.0% |
2022 FY | 405.78 Million CHF | 11.28% |
2022 Q2 | 423.99 Million CHF | 0.0% |
2021 Q2 | 403.48 Million CHF | 0.0% |
2021 Q4 | 364.65 Million CHF | 0.0% |
2021 FY | 364.65 Million CHF | 33.85% |
2020 Q4 | 272.43 Million CHF | 0.0% |
2020 FY | 272.43 Million CHF | 6.02% |
2020 Q2 | 290.44 Million CHF | 0.0% |
2019 Q4 | 256.95 Million CHF | 0.0% |
2019 FY | 256.95 Million CHF | 12.93% |
2019 Q2 | 293.62 Million CHF | 0.0% |
2018 Q4 | 227.54 Million CHF | 0.0% |
2018 FY | 227.54 Million CHF | -8.36% |
2018 Q2 | 251.72 Million CHF | 0.0% |
2017 Q2 | 260.48 Million CHF | 0.0% |
2017 Q4 | 248.29 Million CHF | 0.0% |
2017 FY | 248.29 Million CHF | 1.9% |
2016 Q2 | 274.46 Million CHF | 0.0% |
2016 Q4 | 243.66 Million CHF | 0.0% |
2016 FY | 243.66 Million CHF | -5.16% |
2015 Q2 | 135.74 Million CHF | 0.0% |
2015 Q4 | 256.92 Million CHF | 0.0% |
2015 FY | 256.92 Million CHF | 108.61% |
2014 Q4 | 123.15 Million CHF | 0.0% |
2014 FY | 123.15 Million CHF | 24.25% |
2014 Q2 | 100.93 Million CHF | 0.0% |
2013 Q2 | 105.98 Million CHF | 0.0% |
2013 Q4 | 99.12 Million CHF | 0.0% |
2013 FY | 99.12 Million CHF | -18.55% |
2012 Q2 | 118.02 Million CHF | 0.0% |
2012 FY | 121.7 Million CHF | 9.37% |
2012 Q4 | 121.7 Million CHF | 0.0% |
2011 Q2 | 87.79 Million CHF | 0.0% |
2011 Q4 | 111.27 Million CHF | 0.0% |
2011 FY | 111.27 Million CHF | 5.89% |
2010 Q2 | 127.48 Million CHF | 0.0% |
2010 Q4 | 105.09 Million CHF | 0.0% |
2010 FY | 105.09 Million CHF | -5.37% |
2009 Q4 | 111.05 Million CHF | 0.0% |
2009 FY | 111.05 Million CHF | -24.49% |
2008 FY | 147.06 Million CHF | -8.38% |
2007 FY | 160.52 Million CHF | 4.3% |
2006 FY | 153.89 Million CHF | -0.05% |
2005 FY | 153.96 Million CHF | 15.26% |
2004 FY | 133.58 Million CHF | -11.98% |
2003 FY | 151.77 Million CHF | 6.48% |
2002 FY | 142.53 Million CHF | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Relief Therapeutics Holding AG | 557 Thousand CHF | -77447.217% |
Tecan Group AG | 254.36 Million CHF | -69.808% |
Santhera Pharmaceuticals Holding AG | 1.81 Million CHF | -23750.801% |
Basilea Pharmaceutica AG | 26.41 Million CHF | -1535.509% |
Bachem Holding AG | 340.98 Million CHF | -26.672% |
Molecular Partners AG | - CHF | -Infinity% |